or Try an Advanced Search...

    Technical Analysis for MRNA - Moderna, Inc.

    Grade Last Price % Change Price Change
    F 36.38 -1.52% -0.56
    MRNA closed down 0.94 percent on Wednesday, November 20, 2024, on approximately normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    29 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical MRNA trend table...
    Date Alert Name Type % Chg
    Wide Bands Range Expansion -1.52%
    Oversold Stochastic Weakness -1.52%
    180 Bearish Setup Bearish Swing Setup -2.44%
    Lower Bollinger Band Walk Weakness -2.44%
    Wide Bands Range Expansion -2.44%
    Oversold Stochastic Weakness -2.44%
    Slingshot Bearish Bearish Swing Setup -7.92%
    Lower Bollinger Band Walk Weakness -7.92%
    Wide Bands Range Expansion -7.92%
    Gapped Up Strength -7.92%
    Older End-of-Day Signals for MRNA ...

       Recent Intraday Alerts

    Alert Time
    Fell Below Previous Day's Low 1 minute ago
    Down 1% 1 minute ago
    Down 2 % about 19 hours ago
    60 Minute Opening Range Breakdown about 19 hours ago
    Possible NR7 about 20 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    MRNA Chart by TradingView
    Basic chart:

    Profile

    Moderna, Inc. develops medicines based on messenger RNA (mRNA). Its pipeline includes development candidates for mRNA-based vaccines and therapies for use in various therapeutic areas comprising prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: S&P 500 Cancer Life Sciences Nasdaq 100 Biology Coronavirus Vaccines RNA Cancer Vaccine Messenger RNA

    Is MRNA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 20 CDC warns of an imminent spike in COVID, flu cases
    Nov 20 Moderna initiated with a Hold at Berenberg
    Nov 19 BioNTech started at buy, Moderna at hold by Berenberg
    Nov 19 HSBC upgrades Moderna to Buy on pipeline potential
    Nov 18 Moderna Remains Confident Despite Political Concerns Over Vaccine Safety and HHS Nomination
    Nov 18 Moderna stock climbs as HSBC upgrades to Buy on underestimated pipeline potential
    Nov 18 Moderna's stock decline after RFK Jr's appointment makes an "attractive entry point": Piper Sandler
    Nov 18 Dow Tumbles Over 300 Points Following Economic Reports, Nvidia, Microsoft Decline: Fear & Greed Index Moves To 'Neutral' Zone
    Nov 17 Super Micro Computer, Moderna And XPeng Were Among Top 10 Large Cap Stocks Losing Big Last Week (November 11-15): Check Out Other Losers
    Nov 16 What Moved Markets This Week
    See more MRNA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 170.47
    52 Week Low 35.8
    Average Volume 7,168,233
    200-Day Moving Average 96.68
    50-Day Moving Average 56.13
    20-Day Moving Average 47.70
    10-Day Moving Average 41.58
    Average True Range 2.82
    RSI (14) 20.63
    ADX 37.97
    +DI 13.19
    -DI 39.04
    Chandelier Exit (Long, 3 ATRs) 49.22
    Chandelier Exit (Short, 3 ATRs) 44.27
    Upper Bollinger Bands 61.40
    Lower Bollinger Band 34.00
    Percent B (%b) 0.11
    BandWidth 57.44
    MACD Line -5.77
    MACD Signal Line -4.98
    MACD Histogram -0.7962
    Fundamentals Value
    Market Cap 14.08 Billion
    Num Shares 381 Million
    EPS -9.23
    Price-to-Earnings (P/E) Ratio -4.00
    Price-to-Sales 3.91
    Price-to-Book 2.48
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 39.66
    Resistance 3 (R3) 39.79 39.00 39.21
    Resistance 2 (R2) 39.00 38.31 38.94 39.06
    Resistance 1 (R1) 37.97 37.88 37.58 37.85 38.91
    Pivot Point 37.19 37.19 36.99 37.13 37.19
    Support 1 (S1) 36.16 36.50 35.77 36.03 34.97
    Support 2 (S2) 35.37 36.07 35.31 34.82
    Support 3 (S3) 34.34 35.37 34.67
    Support 4 (S4) 34.22